MANTUANO, FRANCESCO
MANTUANO, FRANCESCO
Borsisti
Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data
2025 Stumpo, S.; Carlini, A.; Mantuano, F.; Di Federico, A.; Melotti, B.; Sperandi, F.; Favorito, V.; De Giglio, A.
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC
2025 Pecci, F.; Li, H.; Di Federico, A.; Wu, J.; Chen, H.; Gariazzo, E.; Mantuano, F.; Garbo, E.; Aldea, M.; Santo, V.; Gibbons, D.; Tran, H.; Paoloni, F.; De Almeida, G. R.; Metro, G.; De Giglio, A.; Gelsomino, F.; Wang, X.; Tiseo, M.; Rotow, J.; Ardizzoni, A.; Lee, J. J.; Awad, M. M.; Addeo, A.; Hong, L.; Negrao, M. V.; Janne, P. A.; Heymach, J. V.; Zhang, J.; Ricciuti, B.; Le, X.
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%
2025 De Giglio, A.; Zullo, L.; Di Federico, A.; Cani, M.; Aldea, M.; Soldato, D.; Dall'Olio, F. G.; Mantuano, F.; Sperandi, F.; Favorito, V.; Sadowska, A.; Hendriks, L. E. L.; Gorria, T.; Mezquita, L.; Tabbo, F.; Novello, S.; Gelsomino, F.; Besse, B.; Ardizzoni, A.
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
2025 Di Federico, A.; Stumpo, S.; Mantuano, F.; De Giglio, A.; Lo Bianco, F.; Pecci, F.; Alessi, J. V.; Wang, X.; Sperandi, F.; Melotti, B.; Gelsomino, F.; Skoulidis, F.; Garassino, M. C.; Peters, S.; Awad, M. M.; Ardizzoni, A.; Ricciuti, B.
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma
2024 Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro; Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data | Stumpo, S.; Carlini, A.; Mantuano, F.; Di Federico, A.; Melotti, B.; Sperandi, F.; Favorito, V.; ...De Giglio, A. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-01750-v2.pdf |
| First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC | Pecci, F.; Li, H.; Di Federico, A.; Wu, J.; Chen, H.; Gariazzo, E.; Mantuano, F.; Garbo, E.; Alde...a, M.; Santo, V.; Gibbons, D.; Tran, H.; Paoloni, F.; De Almeida, G. R.; Metro, G.; De Giglio, A.; Gelsomino, F.; Wang, X.; Tiseo, M.; Rotow, J.; Ardizzoni, A.; Lee, J. J.; Awad, M. M.; Addeo, A.; Hong, L.; Negrao, M. V.; Janne, P. A.; Heymach, J. V.; Zhang, J.; Ricciuti, B.; Le, X. | 2025-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | ccr-25-1735.pdf |
| Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50% | De Giglio, A.; Zullo, L.; Di Federico, A.; Cani, M.; Aldea, M.; Soldato, D.; Dall'Olio, F. G.; Ma...ntuano, F.; Sperandi, F.; Favorito, V.; Sadowska, A.; Hendriks, L. E. L.; Gorria, T.; Mezquita, L.; Tabbo, F.; Novello, S.; Gelsomino, F.; Besse, B.; Ardizzoni, A. | 2025-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | degiglioetal_ESMOOPEN.pdf; mmc1 (1).pdf |
| Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis | Di Federico, A.; Stumpo, S.; Mantuano, F.; De Giglio, A.; Lo Bianco, F.; Pecci, F.; Alessi, J. V....; Wang, X.; Sperandi, F.; Melotti, B.; Gelsomino, F.; Skoulidis, F.; Garassino, M. C.; Peters, S.; Awad, M. M.; Ardizzoni, A.; Ricciuti, B. | 2025-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma | Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro;... Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco | 2024-01-01 | EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | - | 1.01 Articolo in rivista | ERPMDD 2024 [TGR].pdf |